SCIENTIFIC INSIGHTS

HAVE A LOOK AT OUR LATEST SCIENTIFIC INSIGHTS

FIND OUT MORE

JULIUS CLINICAL JOINS

THE COVID-19 CRISIS

FORCES TO HELP TACKLING

to the much-needed scientific leadership,

agile clinical CRO services and network of 1,005 sites

Our ready-to-go setup gives you fast access

VIEW FACTSHEET

LEVERAGE REAL-WORLD EVIDENCE WITH

TAILOR-MADE CLINICAL RESEARCH

MORE INFORMATION

MONITOR TRAINING

SUBSCRIBE NOW FOR June 8 and 15 (2020)

MORE INFORMATION

Science forms the basis of all we do

SCIENCE IS IN OUR DNA

WE'RE HIRING

START YOUR CAREER AT JULIUS CLINICAL

CHECK OUR VACANCIES HERE

FLAWLESS EXECUTION

OF EVERY STUDY

Operational Excellence

WE DARE TO CREATE BOLD

AND IMAGINATIVE SOLUTIONS

Agile and creative

JULIUS CLINICAL – SCIENCE CONTRACT RESEARCH ORGANISATION

GLOBAL & FOCUSED

Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world. Our unique combination of scientific leadership and operational excellence ensures that the trial data is of the highest quality.

We specialise in distinct therapeutic areas including Cardio Metabolic, Infectious diseases and Immunology and Brain. We can offer a full-service proposal or separate functional services as required.

ENT CLINICAL

The academic clinical research organisation with the expertise to support your clinical development program in the hearing field.

RWE & RWD

Julius Clinical’s RWE specialists and data scientists are academic thought leaders in RWE, RWD and the creation of tailor-made studies.

I/I

Julius Clinical’s experience in infectious disease research is epitomized by the CAPiTA study; the largest vaccine trial worldwide.

CARDIO METABOLIC

Julius Clinical has a strong track record of expertise and performance in the field of Cardiovascular diseases and the related field Metabolic diseases.

BRAIN

Julius Clinical is active in the field of diseases affecting the Brain, managing trials involving patients with a range of neurological or psychiatric disorders.

> 39 COUNTRIES

> 130 TRIALS

> 150.000 PATIENTS

IT’S IN OUR DNA

THE UNIQUE TRIANGLE OF JULIUS CLINICAL

We are the Contract Research Organisation (CRO) that combines the latest scientific insights with operational excellence to develop innovative and credible solutions, enabling our clients to bring their treatments to the market faster.

SCIENCE

Science is in our DNA. Julius Clinical starts with science in mind to develop (tailor made) solutions.

SCIENTISTS

A key strength of Julius Clinical is the academic expertise and integrity of our scientific team.

NETWORKS

Julius Clinical has a strong and committed network of academic leaders and investigators around the world.

FULL SERVICE, FLAWLESS EXECUTION

Julius Clinical supports clients throughout their clinical development program; from defining clinical strategy, target population and trial design, through to regulatory submissions, trial set up and training of local staff and to expert monitoring and reporting. Our clinical and statistical experts and specialist data management systems will ensure high quality and timely analysis, interpretation and reporting of your trial data; offering a Full-Service Solution.

SCIENTIFIC SERVICES

Julius Clinical has access to internationally recognised k.o.l’s who can be actively involved in the design, implementation, and interpretation of clinical trials.

PROJECT IMPLEMENTATION

Because of the broad experience, from earlier (similar) studies, Julius Clinical delivers the highest quality in the field of Project Implementation.

PROJECT MANAGEMENT

Julius Clinical has all the staff and systems in place to effectively manage any study, whether it is a small national trial or a large, complex global study.

LATEST SHARES

Using wearable devices to predict COVID-19? Prof. Diederick (Rick) E. Grobbee, MD, PhD, FESC was interviewed by RTL news about the possibilities of the use of a bracelet, that continuously measures at night ones temperature and breathing in order to detect early symptoms of COVID-19.

Watch the interview, which starts at 17.40, by clicking the link below or read the article: https://lnkd.in/dnpceVY (both in Dutch)

https://lnkd.in/djSVQhd

In four days, the ESC will start. With this event being completely digital, we unfortunately do not get the chance to meet with you in person. However, our scientific leaders Prof. Diederick (Rick) E. Grobbee, MD, PhD, FESC and Prof. Marco Alings are very interested in meeting with you virtually and have reserved several timeslots in the coming weeks.

Are you interested in learning how we combine the latest scientific insights with operational excellence in clinical research? Do you want to explore how we can support your clinical trial through our Cardio Clinical network? Book a meeting with one of our key opinion leaders https://lnkd.in/d2UKuGV or get in contact with Ilse Gonella.

SEE ALL THE SHARES